Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 5 | 2026 | 137 | 1.440 |
Why?
|
| Drug Overdose | 3 | 2021 | 62 | 0.870 |
Why?
|
| Prescriptions | 2 | 2023 | 28 | 0.820 |
Why?
|
| Radiculopathy | 1 | 2023 | 5 | 0.810 |
Why?
|
| Musculoskeletal Pain | 1 | 2023 | 26 | 0.790 |
Why?
|
| Vietnam | 9 | 2026 | 42 | 0.740 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 239 | 0.700 |
Why?
|
| Maltose-Binding Proteins | 2 | 2017 | 2 | 0.660 |
Why?
|
| Quality of Life | 1 | 2023 | 477 | 0.630 |
Why?
|
| Caregivers | 3 | 2026 | 132 | 0.610 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 12 | 0.530 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 305 | 0.480 |
Why?
|
| Criminal Law | 3 | 2020 | 10 | 0.440 |
Why?
|
| Humans | 18 | 2026 | 16832 | 0.430 |
Why?
|
| Prisoners | 3 | 2020 | 53 | 0.410 |
Why?
|
| Health Personnel | 2 | 2026 | 132 | 0.370 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 1233 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2023 | 290 | 0.330 |
Why?
|
| Adult | 9 | 2026 | 7255 | 0.300 |
Why?
|
| Male | 10 | 2026 | 9556 | 0.290 |
Why?
|
| Recidivism | 2 | 2019 | 3 | 0.280 |
Why?
|
| Female | 11 | 2026 | 12193 | 0.280 |
Why?
|
| Retrospective Studies | 4 | 2025 | 2463 | 0.270 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 2 | 0.260 |
Why?
|
| Escherichia coli | 2 | 2017 | 8 | 0.250 |
Why?
|
| Aged | 7 | 2026 | 5901 | 0.250 |
Why?
|
| Outpatients | 2 | 2025 | 99 | 0.240 |
Why?
|
| Inappropriate Prescribing | 1 | 2025 | 9 | 0.230 |
Why?
|
| Polypharmacy | 1 | 2025 | 16 | 0.230 |
Why?
|
| Terminal Care | 1 | 2026 | 48 | 0.230 |
Why?
|
| Family | 1 | 2026 | 99 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 51 | 0.210 |
Why?
|
| Headache | 1 | 2023 | 11 | 0.200 |
Why?
|
| Back Pain | 1 | 2023 | 32 | 0.200 |
Why?
|
| Olfaction Disorders | 1 | 2023 | 1 | 0.200 |
Why?
|
| Smell | 1 | 2023 | 2 | 0.200 |
Why?
|
| Needs Assessment | 1 | 2023 | 64 | 0.200 |
Why?
|
| Stress, Psychological | 1 | 2024 | 136 | 0.190 |
Why?
|
| Prisons | 2 | 2020 | 28 | 0.180 |
Why?
|
| Young Adult | 4 | 2025 | 2456 | 0.180 |
Why?
|
| Consumer Health Informatics | 1 | 2020 | 1 | 0.160 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 10 | 0.160 |
Why?
|
| Mass Screening | 1 | 2025 | 670 | 0.150 |
Why?
|
| Colorado | 1 | 2020 | 171 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.150 |
Why?
|
| Rubella Vaccine | 1 | 2019 | 8 | 0.150 |
Why?
|
| Judicial Role | 1 | 2019 | 2 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 56 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 352 | 0.140 |
Why?
|
| Violence | 1 | 2019 | 32 | 0.140 |
Why?
|
| Adolescent | 3 | 2025 | 3464 | 0.140 |
Why?
|
| Vaccination Coverage | 1 | 2019 | 68 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 289 | 0.140 |
Why?
|
| Prokaryotic Cells | 1 | 2017 | 1 | 0.130 |
Why?
|
| Thioredoxins | 1 | 2017 | 1 | 0.130 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2017 | 1 | 0.130 |
Why?
|
| Middle Aged | 6 | 2026 | 7515 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1058 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 3 | 0.120 |
Why?
|
| Incidence | 1 | 2020 | 1229 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 1887 | 0.100 |
Why?
|
| Child | 1 | 2020 | 2433 | 0.100 |
Why?
|
| Michigan | 2 | 2020 | 26 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 653 | 0.060 |
Why?
|
| Attitude to Death | 1 | 2026 | 7 | 0.060 |
Why?
|
| Risk Factors | 2 | 2025 | 3108 | 0.060 |
Why?
|
| Potentially Inappropriate Medication List | 1 | 2025 | 2 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 13 | 0.060 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2025 | 14 | 0.060 |
Why?
|
| Vaccines, Synthetic | 1 | 2025 | 39 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 138 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2026 | 288 | 0.050 |
Why?
|
| Culturally Competent Care | 1 | 2024 | 10 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2026 | 197 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 70 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 2396 | 0.050 |
Why?
|
| Odorants | 1 | 2023 | 3 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 346 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 19 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 36 | 0.040 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2019 | 1 | 0.040 |
Why?
|
| Occupations | 1 | 2019 | 15 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 32 | 0.040 |
Why?
|
| Rubella | 1 | 2019 | 6 | 0.040 |
Why?
|
| Public Policy | 1 | 2019 | 14 | 0.040 |
Why?
|
| Parity | 1 | 2019 | 53 | 0.040 |
Why?
|
| Rural Population | 1 | 2019 | 58 | 0.040 |
Why?
|
| Educational Status | 1 | 2019 | 163 | 0.040 |
Why?
|
| Urban Population | 1 | 2019 | 105 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 174 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 158 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 1 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 1 | 0.030 |
Why?
|
| Plasmids | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cricetinae | 1 | 2016 | 2 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 6 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 15 | 0.030 |
Why?
|
| Animals | 1 | 2016 | 237 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 1555 | 0.030 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->